Starling Oncology, Inc. Increase (Decrease) in Assets Held-for-sale
Starling Oncology, Inc. (STLN) reported Increase (Decrease) in Assets Held-for-sale of -$3.72 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAssetsHeldForSale · last filed 2022-11-09
- Starling Oncology, Inc. increase (decrease) in assets held-for-sale for the quarter ending 2022-09-30 was -$1.53M.
- Starling Oncology, Inc. increase (decrease) in assets held-for-sale for the quarter ending 2022-06-30 was -$1.25M.
- Starling Oncology, Inc. increase (decrease) in assets held-for-sale for the quarter ending 2022-03-31 was -$942.00K.
- Starling Oncology, Inc. increase (decrease) in assets held-for-sale for the quarter ending 2021-09-30 was $0.00.
| Period end | Increase (Decrease) in Assets Held-for-sale 3 month | Increase (Decrease) in Assets Held-for-sale 6 month | Increase (Decrease) in Assets Held-for-sale 9 month |
|---|---|---|---|
| 2022-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.78M derived: sum of 2 quarters · filed 2022-11-09 | -$3.72M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.19M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$942.00K 10-Q · filed 2022-05-10 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 |